BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and …

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and …

Get the latest news on biotech funding, stocks, mergers and acquisitions, IPOs, bankruptcies, and more from BioSpace.

Mar 16, 2026 · Sana Biotechnology is looking to start clinical development for its type 1 diabetes therapy SC451 this year. Sana Biotechnology’s investigational allogeneic islet cell therapy has survived and …

3 days ago · Browse the latest news from BioSpace, and press releases from around the industry. Want to filter by date, keyword, and more? Search here.

4 days ago · The deals keep rolling in, with Lilly penning a $7 billion pact for gene delivery biotech Kelonia Therapeutics and UCB taking over cell therapy-focused Neurona Therapeutics; President …

May 6, 2025 · The analysts noted, however, that “Makary does not seem to want to disrupt oncology and rare disease approvals.” The S&P Biotech ETF fell by more than 5% upon news of Prasad’s …

Aug 2, 2024 · As part of a major reorganization, Vir Biotechnology has discontinued the bulk of its virology work and pivoted to cancer in an exclusive licensing deal with Sanofi.

Feb 12, 2025 · Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer stepped in as CEO to answer a critical question: What’s next?

Jan 7, 2025 · China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.